FGF23 can be also produced by malignancies including colon adenocarcinoma, ovarian cancer, small cell carcinoma of the lung, anaplastic thyroid carcinoma, B-cell non-Hodgkin lymphoma, breast cancer, and intracranial tumours. Here, FGF23 is linked to thyroid gland undifferentiated (anaplastic) carcinoma.